FAIR VALUE DISCLOSURES (Tables)

3 Months Ended

Mar. 31, 2026

Fair Value Disclosures [Abstract]

Schedule of Face Value, Carrying Amounts and Fair Value

The following were the face values, carrying amounts and fair values of the Company’s notes payable as of March 31, 2026 and December 31, 2025, which carrying amounts generally do not approximate the fair values (in thousands):

	March 31, 2026						December 31, 2025
	Face Value		Carrying Amount		Fair Value		Face Value		Carrying Amount		Fair Value
Financial liabilities:
Notes payable	$	1,245,408	$	1,237,067	$	1,215,543	$	1,293,394	$	1,282,652	$	1,274,576

Schedule of Assets at Fair Value

As of March 31, 2026, the Company measured the following assets and liabilities at fair value (in thousands):

			Fair Value Measurements Using
	Total		Quoted Prices in Active Markets  for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Recurring Basis:
Real estate equity securities	$	40,600	$	40,600	$	—	$	—
Asset derivatives - interest rate swaps	$	469	$	—	$	469	$	—
Liability derivatives - interest rate swaps	$	(70)	$	—	$	(70)	$	—

During the three months ended March 31, 2026, the Company measured the following asset at fair value on a nonrecurring basis (in thousands):

			Fair Value Measurements Using
	Total		Quoted Prices in Active Markets  for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Nonrecurring Basis:
Impaired real estate (1)	$	97,000	$	—	$	—	$	97,000

_____________________

(1) Amount represents the fair value for a real estate asset impacted by an impairment charge during three months ended March 31, 2026, as of the date that the fair value measurement was made, which was March 31, 2026.